National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation

Cancer

Volumn 103, Issue 9, 2005, Pages 1891-1897

  Bleyer, Archie ^a,b,c   Montello, Michael ^d   Budd, Troy ^d   Saxman, Scott ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adolescents; Clinical trials; Sarcoma survival; Young adults

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; CHILD; CLINICAL TRIAL; GYNECOLOGIC CANCER; HUMAN; INFANT; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; OSTEOSARCOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; SARCOMA; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; MORTALITY; REGISTRIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 17644424627     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20995     Document Type: Article

References (24)

1. Bleyer A, Ries L. United States cancer incidence, mortality and survival: young adults are lagging further behind. Proc Am Soc Clin Oncol. 2002;21:389a.
2. Bleyer WA. Overview: cancer in adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002;38:1-10.
3. Bleyer A, Montello M, Budd T, Kelahan A, Ries L. U.S. cancer incidence, mortality and survival: young adults are lagging further behind. American Society of Clinical Oncology, 2002. Available from URL: http://www.asco.org/ac/ 1,1003,_12-002511-00_18-0016-00_19-001907,00.asp (select slides) [accessed March 10, 2005).
4. Bleyer A, Montello M, Budd T. Young adults with leukemia in the United States: Lack of clinical trial participation and mortality reduction during the last decade [abstract 6623]. Proc Am Soc Clin Oncol. 2004;23:586.
5. Bleyer A, Hag-Alshiekh M, Montello M, et al. Older adolescents and young adults with brain tumors in the United States: lack of clinical trial participation and of survival prolongation and mortality reduction. Proc Intl Symp Pediatr Neurooncol. 2004:52.
6. Mitchell AE, Scarcella DL, Rigutto GL, et al. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust. 2004;180:59-62.
7. Bleyer A, Montello M, Budd T, Saxman S. Young Adults with sarcoma: lack of clinical trial participation and lack of survival prolongation [abstract 3280]. Proc Am Soc Clin Oncol. 2003;22:816.
8. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1975-2000. Bethesda: National Cancer Institute, 2003. Available from URL: http://seer.cancer.gov/ csr/1975_2000, 2003 [accessed June 19, 2003].
9. Bleyer A, Albritton K. Special considerations for the young adult and adolescent. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Holland JF, Frei E, editors. Holland-Frei: cancer medicine. 6th edition. Hamilton, ON, Canada: BC Decker, 2003:2414-2422.
10. General Accounting Office. Analysis of the March 2000 current population survey of nonelderly (under 65). Washington, DC: General Accounting Office, 2000.
11. Bleyer A. Older adolescents with cancer in North America: deficits in outcome and research. Pediatr Clin North Am. 2002;49:1027-4211.
12. Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am. 1997;44:973-989.
13. Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol. 2003;40:276-287.
14. Rauck AM, Fremgen AM, Hutchison CL, et al. Adolescent cancers in the United States: a National Cancer Data Base (NCDB) report. J Pediatr Hematol Oncol. 1999;21:310.
15. Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;15:2719-2725.
16. Paulussen S, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies [abstract 3279). Proc Am Soc Clin Oncol. 2003;22:816.
17. Nachman J, Sather HN, Buckley JD, et al. Young adults 16-21 years of age at diagnosis entered onto Children's Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment. Cancer. 1993;71:(10 Suppl),3377-3385.
18. Stock W, Sather H, Dodge RK, Bloomfleld CD, Larson A, Nachman J. Outcome of adolescents and young adults with ALL: a comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group G (CALGB) regimens. Blood. 2000;96:467a.
19. de Bont JM, B. van der Holt B, Dekker AW, et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric versus adult ALL protocols in the Netherlands. Leukemia. 2004;18:2032-2053.
20. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003;21:774-780.
21. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003;98:571-580.
22. Bleyer WA, Tejeda H, Murphy SM, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997;21:366-373.
23. Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996;88:812-816.
24. Cole CH. Doing better with cancer in adolescents and young adults. Med J Aust. 2004;180:52-53.